| 发明名称 |
COMBINED USE OF CTLA-4 BLOCKING AGENT AND LYMPHOTOXIC THERAPY IN TUMOR TREATMENT |
| 摘要 |
T Cell activation in response to antigen is increased by the administration of binding agents that block CTLA-4 signaling. When CTLA-4 signaling is thus blocked, the T cell response to antigen is released from inhibition. Such an enhanced response is useful for the treatment of tumors, chronic viral infections, and as an adjuvant during immunization. |
| 申请公布号 |
PT2332561(E) |
申请公布日期 |
2016.06.14 |
| 申请号 |
PT20100180032T |
申请日期 |
1996.12.04 |
| 申请人 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
发明人 |
PATRICK JAMES ALLISON;DANA R. LEACH;MATTHEW F KRUMMEL |
| 分类号 |
A61K45/06;C12N15/02;A61K31/00;A61K38/00;A61K38/17;A61K38/19;A61K39/00;A61K39/085;A61K39/39;A61K39/395;A61K45/00;A61N5/10;A61P13/00;A61P13/12;A61P31/00;A61P31/12;A61P35/00;A61P37/00;A61P37/04;A61P43/00;C07K14/31;C07K14/705;C07K14/725;C07K16/28;C12N15/09;C12P21/08 |
主分类号 |
A61K45/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
